PubMed Health⌕ Search

Biomedical subjects

J H Wilkinson

Publications and source records attributed to J H Wilkinson.

At least 19 recordsLinked to original sources
PubMed1983

Exploring sensory integrative dysfunction in process schizophrenia.

During a 6-week period, the effects of sensory integrative activities on a group of seven chronic nonparanoid schizophrenic adults were compared to the effects of sedentary activities in a control group of seven similar subjects. The effects of each therapeutic approach were evaluated by measuring the patients' performance in several areas using the Nurses Observation Scale of Inpatient Evaluation-30 (NOSIE-30), The Object Manipulation Speed Test, a gait analysis, and grip strength. The results indicated general improvement in the experimental group. Behaviors measured by the NOSIE-30 showed the most significant improvements. The control group showed isolated improvements in grooming (measured by the NOSIE-30) and in right-hand use (measured by The Object Manipulation Speed Test). These findings suggest that 6 weeks of sensory integrative activities can improve the overall functioning of chronic nonparanoid schizophrenic patients, facilitate their adaptive responses, and enable them to participate more fully in other areas of therapeutic intervention.

Adult↗
PubMed1977

Action of adenosine hosphates on the release of intracellular lactate dehydrogenase from human and rat lymphocytes.

Differences in the action of adenosine phosphates on the release of intracellular enzymes from human and rat lymphocytes have been studied. The protective effect of ATP on the human cells was found to be less than on the rat cells. The greatest discrepancy was exhibited by AMP which exerted a protective effect on human lymphocytes, but increased enzyme efflux from rat lymphocytes. The activities of adenosine kinase, adenylate kinase, phosphoribosyl-pyrophosphate synthetase, pyruvate kinase, phosphoglycerate kinase and creatine kinase were compared in the cells of both species. Although significant differences were observed, they were too small to suggest the presence of a mechanism for the conversion of AMP into ATP in human lymphocytes not found in the rat cells. It seems therefore that the protective effect exerted by AMP on the human cells is not mediated by its conversion into ATP, and hence that some factor other than the intracellular energy content is concerned in controlling the release of intracellular enzymes from human cells.

Adenosine Monophosphate↗
PubMed1977

Inactivation in vitro of lactate dehydrogenase-5 in blood.

During incubation with rabbit blood in vitro rabbit-muscle lactate dehydrogenase-5 was inactivated at a rate similar to that observed in vivo. By contrast plasma and plasma containing erythrocytes had no effect on the enzyme activity, but plasma containing leucocytes inactivated the enzyme at the same rate as whole blood. The results obtained support the concept that intravascular inactivation accounts for the diappearance of enzymes from the circulation.

Animals↗
PubMed1976

Membrane permeability in normal human lymphocytes and lymphocytes from patients with chronic lymphatic leukaemia.

The rate of release of intracellular enzymes from the lymphocytes of patients with chronic lymphatic leukaemia has been shown to be slower than that from normal lymphocytes, despite their lower enzyme contents. Addition of ATP, ADP and AMP to the medium reduces enzyme efflux in a manner similar to that in normal lymphocytes. Iodoacetate, however, causes a marked increase in enzyme leakage from both normal and leukaemic cells. It appears therefore that the membrane permeability of leukaemic lymphocytes is at least partly dependent upon the intracellular energy content. Since the ATP contents of the leukaemic cells were lower than those of normal lymphocytes, however, it is concluded that some additional factor is concerned in reducing permeability to enzymes in chronic lymphatic leukaemia. The possibility that the immunoglobulin associated with the cell membrane of leukaemic cells may play a part in reducing its permeability has been explored, but washed and unwashed cells were found to lose enzymes at similar rates. The lower permeability of the membranes of such cells may partly explain their longer lifespan in chronic lymphatic leukaemia.

Adenosine Diphosphate↗
PubMed1976

Action of metabolic inhibitors on the release of intracellular enzymes from human and rat lymphocytes and human erythrocytes.

A number of inhibitors of glycolysis and uncouplers of oxidative phosphorylation have been shown to increase the leakage of intracellular enzymes from preparations of rat lymphocytes and human lymphocytes and erythrocytes. The effect of each reagent on all three cell preparations is reversed in the presence of ATP in the medium. ADP is somewhat less effective. AMP exerts a slight protective effect on the human cells, but causes an increase in enzyme efflux from the rat cells. This species difference appears to be related to the concentration of adenylate kinase activity in the cells. The results are interpreted as supporting the theory that membrane permeability to enzymes and other intracellular proteins is dependent upon the energy content of the cell.

Adenosine Diphosphate↗
PubMed1976

The fate of circulating lactate dehydrogenase-5 in the rabbit.

1. In an attempt to determine the mechanism whereby enzymes are removed from the circulating plasma, purified rabbit-muscle lactate dehydrogenase-5 was labelled with 125I and injected intravenously into rabbits. During the first hour after injection enzyme activity and radioactivity disappeared from the plasma at comparable fast rates, which are attributed mainly to distribution of the enzyme throughout the extracellular fluid. This was followed by a phase lasting about 7 h during which enzyme activity disappeared at a faster rate than the radioactivity, an observation indicating either intravascular breakdown of the enzyme protein or its degradation in the tissues, followed by release of labelled fragments into the circulation. Enzyme activity then reached a constant value and the plasma radioactivity continued to decrease at a slower exponential rate; it is suggested that this is due to removal of breakdown products. 2. The radioactivity of the tissues was measured at various time-intervals after injection. After 2 h and 8 h highest concentrations were found in the spleen, liver, jejunum and duodenum. Relatively high concentrations were also found in the intestinal juices throughout the period of study, an observation which suggests that discharge via the small intestine is a major route whereby inactivated enzyme fragments are removed from the circulation. 3. About 5% of the injected radioactivity was recovered in the faeces during the first 3 days, and the urine accounted for 73% during the same period. About 35% of the urinary radioactivity was shown by silver nitrate precipitation and by chromatography to consist of free iodide and the remainder appeared to consist of radio-iodinated amino acids or peptides. Free mono- and di-iodotyrosine were identified among the products. These results suggest that further breakdown in the intestine is followed by absorption of the products, which are excreted in the urine.

Animals↗
PubMed1976

Catabolism of plasma enzymes, as studied with 125I-labeled lactate dehydrogenase-1 in the rabbit.

Circulating enzymes may be inactivated in the plasma and the inactive breakdown products may be hydrolyzed in the lumen of the small intestine. Evidence for this mechanism was based upon previous studies with 125I-labeled lactate dehydrogenase-5, and here similar studies with radioiodinated lactate dehydrogenase-1 are reported, to determine whether this isoenzyme is similarly catabolized. The pure rabbit enzyme was labeled with 125I by use of lactoperoxidase and hydrogen peroxide (the labeled enzyme had 80-85% of the original catalytic activity). After its intravenous injection into rabbits, plasma enzyme activity and radioactivity disappeared during the first 4 h at similar fast rates, apparently because of distribution of the injected enzyme throughout the extracellular fluid. During a second phase (30-h), catalytic activity disappeared significantly faster than radioactivity, suggesting inactivation of the enzyme in either the plasma or a compartment in close proximity to it, or both. Enzyme activity then remained constant while plasma radioactivity continued to decrease at a slower, exponential rate, apparently owing to removal of breakdown products. In no case did tissue radioactivity, studied 6 h after injection, approach that of plasma. We therefore conclude that removal of the enzyme protein or its breakdown products is a passive process. Appreciable radioactivity was detected in the intestinal contents, a finding which suggests that removal via the small intestine is an important route for the removal of inactivated enzyme products from the circulation. Less than 3% of the injected radioactivity appeared in the feces during the first three days; urinary excretion accounted for about 67% during the same period, about 60% of which consisted of radio-iodinated amino-acids, the remainder of iodide. Free mono- and di-iodotyrosines were among the products excreted. These appear to originate from absorption of the products of further breakdown of the enzyme molecule in the intestine.

Animals↗
PubMed1976

Rates of disappearance from plasma of enzymes labeled by coupling with a radioactive lodo-ester.

Lactate dehydrogenase-5 and creatine kinase from rabbit muscle were labeled by coupling with N-hydroxysuccinimidyl 3-(4'-hydroxy-[3',5'-125I]diiodophenyl)propionate. After purification, the analytical recovery of catalytically-active labeled enzyme averaged 90% for lactate dehydrogenase, 81% for creatine kinase. The labeled enzymes were injected intravenously into rabbits and disappearance from plasma of catalytic activity and radioactivity was measured. The disappearance curves for lactate dehydrogenase-5 differed considerably from those observed with the enzyme labeled by direct iodination. The discrepancy was due to rapid hydrolysis in vivo of the labeled amide-enzyme linkage, because about 50% of the injected radioactivity appeared in the urine as 125I-labeled 3-(4'-hydroxy-3',5'-diiodophenyl)propionic acid within 4-8 h of injection. Similar outputs were observed after administration of this acid to rabbits. The free acid was also detected in the urines of rabbits within 4-8 h of the intravenous injection of creatine kinase labeled similarly. We conclude that this method of labeling is unsuitable for preparing radioactive enzymes for study of their catabolism.

Animals↗
PubMed1975

The origin of the elevated activities of creatine kinase and other enzymes in the sera of patients with myxoedema.

An attempt has been made to establish the origin of the elevated serum creatine kinase which occurs in most patients with myxoedema. Parallel determinations of a number of other serum enzymes were made but the incidence of elevated values was appreciably less than in the case of creatine kinase. Rather surprisingly, the serum amylase activity was found to be increased in more than 50% of the patients studied. Creatine kinase isoenzymes were separated by starch-gel electrophoresis of the sera of 26 patients with myxoedema. In 25 the MM isoenzyme only could be identified while the remaining serum also contained a trace of the MB fraction. Similar isoenzyme studies were made with the sera of normal and thyroidectomized rats, all of which are shown to contain all three isoenzymes. (MM, MB and BB) irrespective of thyroid functional status. No consistent difference was apparent between the patterns exhibited by the thyroidectomized and control groups, and it was concluded that thyroidectomized rats cannot be regarded as a suitable experimental model for the study of this aspect of human hypothyroidism. It is suggested that enzyme release in myxoedema is a non-specific effect, possibly die to diminution in the ATP content of tissues generally. The greater incidence of creatine kinase elevation is probably due to the relatively high concentrations of this enzyme in skeletal muscle, the mass of which is much greater than that of any other tissue.

Adenylate Kinase↗